CORC

在结果中检索

CORC

浏览/检索结果: 共214条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Gamma-ray performance study of the HERD payload 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Adriani, O.;  Alemanno, F.;  Aloisio, R.;  Altomare, C.;  Ambrosi, G.
收藏  |  浏览/下载：21/0  |  提交时间：2023/01/16
Design and expected performances of the large acceptance calorimeter for the HERD space mission 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Pacini, Lorenzo;  Adriani, Oscar;  Bai, Yong-Lin;  Bao, Tian-Wei;  Berti, Eugenio
收藏  |  浏览/下载：35/0  |  提交时间：2022/12/30
The High Energy cosmic-Radiation Detector (HERD) Trigger System 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Velasco, M. A.;  Bao, T.;  Berti, E.;  Bonvicini, V.;  Casaus, J.
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/30
InteractGAN: Learning to Generate Human-Object Interaction 会议论文
美国西雅图, 2020年10月12日 – 2020年10月16日
作者:  Gao, Chen;  Liu, Si;  Zhu, Defa;  Liu, Quan;  Cao, Jie
收藏  |  浏览/下载：9/0  |  提交时间：2021/06/16
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05
Contact Force/Torque Prediction and Analysis Model for Large Length-diameter Ratio Peg-in-hole Assembly 会议论文
马来西亚, 2018.12.12-2018.12.15
作者:  Yuchen Wang;  Peng Wang;  Changchun Liu;  Gaoming Hao;  Zhao Xiong
收藏  |  浏览/下载：62/0  |  提交时间：2019/05/09

©版权所有 ©2017 CSpace - Powered by CSpace